AXL x FGFRs x MerTK x PDGFRs x VEGFR2 x VEGFR3 x c-Kit

The purpose of this study is to establish a prospective, multi-center platform research based on clinical subtypes to explore precision therapy in patients hormone-receptor-positive HER2-negative advanced breast cancer who had previously used CDK4/6 inhibitors.